NCT07247227 2025-11-25
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Peking Union Medical College
Phase NA Recruiting
Clinical Trials
4 trialsNCT06217757 2024-05-13
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Sichuan University
Phase 1/2 Recruiting
NCT06031597 2023-09-13
Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT05940532 2023-07-11
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Hunan Cancer Hospital
Phase 2 Recruiting